UK Biobank SARS-CoV-2 Serology Study

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: C19-IUC-227

Grant search

Key facts

  • Disease

    COVID-19
  • Funder

    UK Research and Innovation (UKRI)
  • Principle Investigator

    Pending
  • Research Location

    United Kingdom, Europe
  • Lead Research Institution

    UK Biobank
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    Gender

  • Study Subject

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Thousands of UK Biobank participants are being asked to take part in a major government study to measure the extent of coronavirus infection in different regions across the UK. Those who agree to take part will provide monthly blood samples for at least six months so that their levels of immunity (antibodies in their blood) can be measured. Researchers will use the information to determine the extent of the infection in different regions across the UK and to understand how long antibody levels persist following infection. This major study will complement existing studies, such as the ONS Covid-19 Infection Survey, which through nasal swabs is testing for presence of the virus and will collect blood samples from 1,000 adults in English households. By collecting blood samples from 20,000 participants across the UK to understand immunity to Covid-19, UK Biobank will contribute to national efforts to ease lock-down measures.